FOXA1 and posterior cortical atrophy: To investigate the major polyubiquitin‐mediated degradation pathways, we assessed FOXA1 levels in PCa cells after a 4‐h treatment with either MG‐132 (an inhibitor of the proteasomal degradation) or chloroquine (an inhibitor for the lysosomal degradation).